本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Cellectis S.A.

3.38
+0.18505.80%
成交量:1.47萬
成交額:4.97萬
市值:3.41億
市盈率:-5.21
高:3.47
開:3.33
低:3.31
收:3.19
52周最高:5.48
52周最低:2.35
股本:1.01億
流通股本:7,470.04萬
量比:0.74
換手率:0.02%
股息:- -
股息率:- -
每股收益(TTM):-0.6479
每股收益(LYR):-0.6740
淨資產收益率:-94.54%
總資產收益率:-11.67%
市淨率:8.30
市盈率(LYR):-5.01

資料載入中...

公司資料

公司名字:
Cellectis S.A.
交易所:
NASDAQ
成立時間:
1999
員工人數:
227
公司地址:
8, rue de la Croix Jarry,Paris,Ile-de-France,France
郵編:
75013
傳真:
- -
簡介:
Cellectis S.A.於2000年1月4日成立。該公司是一家處於臨床階段的生物技術公司,利用他們的核心專有技術開發基於基因編輯的產品,擁有一系列同種異體嵌合抗原受體T細胞,即免疫腫瘤學領域的候選產品和基因編輯造血干細胞和祖細胞,即HSPC,其他治療適應症的候選產品。

董事

名稱
職位
Andre Choulika
Director, Chief Executive Officer and Co-Founder
David Sourdive
Director, Deputy Chief Executive Officer, Executive Vice President, CMC and Manufacturing
Jean Pierre Garnier
Chairman of the Board and Director
André Muller
Independent Director
Cécile Chartier
Independent Director
Donald A. Bergstrom
Independent Director
Laurent Arthaud
Independent Director
Marc Dunoyer
Independent Director
Rainer Boehm
Independent Director
Tyrell Rivers
Independent Director

股東

名稱
職位
Andre Choulika
Director, Chief Executive Officer and Co-Founder
David Sourdive
Director, Deputy Chief Executive Officer, Executive Vice President, CMC and Manufacturing
Arthur Stril
Chief Business Officer and Chief Financial Officer
Steven Doares
Senior Vice President of US Manufacturing
Adrian Kilcoyne
Chief Medical Officer
Kyung Nam Wortman
Chief Human Resources Officer
Marie Bleuenn Terrier
General Counsel
Philippe Duchateau
Chief Scientific Officer
Stephan Reynier
Chief Regulatory & Pharmaceutical Compliance Officer